Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Radiology
Published in: European Radiology 10/2012

01-10-2012 | Magnetic Resonance

Prediction of prostate cancer extracapsular extension with high spatial resolution dynamic contrast-enhanced 3-T MRI

Authors: B. Nicolas Bloch, Elizabeth M. Genega, Daniel N. Costa, Ivan Pedrosa, Martin P. Smith, Herbert Y. Kressel, Long Ngo, Martin G. Sanda, William C. DeWolf, Neil M. Rofsky

Published in: European Radiology | Issue 10/2012

Login to get access

Abstract

Objectives

To assess the value of dynamic contrast-enhanced (DCE) combined with T2-weighted (T2W) endorectal coil (ERC) magnetic resonance imaging (MRI) at 3 T for determining extracapsular extension (ECE) of prostate cancer.

Methods

In this IRB-approved study, ERC 3-T MRI of the prostate was performed in 108 patients before radical prostatectomy. T2W fast spin-echo and DCE 3D gradient echo images were acquired. The interpretations of readers with varied experience were analysed. MRI-based staging results were compared with radical prostatectomy histology. Descriptive statistics were generated for prediction of ECE and staging accuracies were determined by the area under the receiver-operating characteristic curve.

Results

The overall sensitivity, specificity, positive predictive value and negative predictive value for ECE were 75 %, 92 %, 79 % and 91 %, respectively. Diagnostic accuracy for staging was 86 %, 80 % and 91 % for all readers, experienced and less experienced readers, respectively.

Conclusions

ERC 3-T MRI of the prostate combining DCE and T2W imaging is an accurate pretherapeutic staging tool for assessment of ECE in clinical practice across varying levels of reader experience.

Key Points

• Endorectal coil (ERC) magnetic resonance imaging is widely used for imaging prostatic disease.
• ERC 3-T MRI is reasonably accurate for local prostate cancer staging.
• High diagnostic accuracy is achievable across different levels of reader experience.
• MRI facilitates therapeutic decisions in patients with prostate cancer.
Literature
1.
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics. CA: A Cancer J Clin 59:225–249CrossRef
2.
3.
Schnall MD, Lenkinski RE, Pollack HM, Imai Y, Kressel HY (1989) Prostate: MR imaging with an endorectal surface coil. Radiology 172:570–574PubMed
4.
Bloch BN, Furman-Haran E, Helbich TH et al (2007) Prostate cancer: accurate determination of extracapsular extension with high-spatial-resolution dynamic contrast-enhanced and T2-weighted MR imaging–initial results. Radiology 245:176–185PubMedCrossRef
5.
Brown G, Macvicar DA, Ayton V, Husband JE (1995) The role of intravenous contrast enhancement in magnetic resonance imaging of prostatic carcinoma. Clin Radiol 50:601–606PubMedCrossRef
6.
Chelsky MJ, Schnall MD, Seidmon EJ, Pollack HM (1993) Use of endorectal surface coil magnetic resonance imaging for local staging of prostate cancer. J Urol 150:391–395PubMed
7.
Hricak H (1988) Noninvasive imaging for staging of prostate cancer: magnetic resonance imaging, computed tomography, and ultrasound. NCI Monogr 7:31–35
8.
Hricak H, White S, Vigneron D et al (1994) Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal–pelvic phased-array coils. Radiology 193:703–709PubMed
9.
Ikonen S, Karkkainen P, Kivisaari L et al (1998) Magnetic resonance imaging of clinically localized prostatic cancer. J Urol 159:915–919PubMedCrossRef
10.
Jager GJ, Ruijter ET, van de Kaa CA et al (1996) Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology. AJR Am J Roentgenol 166:845–852PubMed
11.
Jager GJ, Ruijter ET, van de Kaa CA et al (1997) Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results. Radiology 203:645–652PubMed
12.
Perrotti M, Kaufman RP Jr, Jennings TA et al (1996) Endo-rectal coil magnetic resonance imaging in clinically localized prostate cancer: is it accurate? J Urol 156:106–109PubMedCrossRef
13.
Quinn SF, Franzini DA, Demlow TA et al (1994) MR imaging of prostate cancer with an endorectal surface coil technique: correlation with whole-mount specimens. Radiology 190:323–327PubMed
14.
15.
Sanchez-Chapado M, Angulo JC, Ibarburen C et al (1997) Comparison of digital rectal examination, transrectal ultrasonography, and multicoil magnetic resonance imaging for preoperative evaluation of prostate cancer. Eur Urol 32:140–149PubMed
16.
Jager GJ, Barentsz JO, Oosterhof GO, Witjes JA, Ruijs SJ (1996) Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional TI-weighted magnetization-prepared-rapid gradient-echo sequence. AJR Am J Roentgenol 167:1503–1507PubMed
17.
Engelbrecht MR, Jager GJ, Laheij RJ, Verbeek AL, van Lier HJ, Barentsz JO (2002) Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis. Eur Radiol 12:2294–2302PubMed
18.
Sonnad SS, Langlotz CP, Schwartz JS (2001) Accuracy of MR imaging for staging prostate cancer: a meta-analysis to examine the effect of technologic change. Acad Radiol 8:149–157PubMedCrossRef
19.
Mullerad M, Hricak H, Wang L, Chen HN, Kattan MW, Scardino PT (2004) Prostate cancer: detection of extracapsular extension by genitourinary and general body radiologists at MR imaging. Radiology 232:140–146PubMedCrossRef
20.
Buckley DL, Roberts C, Parker GJ, Logue JP, Hutchinson CE (2004) Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging–initial experience. Radiology 233:709–715PubMedCrossRef
21.
Oyen RH (2003) Dynamic contrast-enhanced MRI of the prostate: is this the way to proceed for characterization of prostatic carcinoma? Eur Radiol 13:921–924PubMed
22.
Padhani AR, Gapinski CJ, Macvicar DA et al (2000) Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol 55:99–109PubMedCrossRef
23.
Preziosi P, Orlacchio A, Di Giambattista G et al (2003) Enhancement patterns of prostate cancer in dynamic MRI. Eur Radiol 13:925–930PubMed
24.
Schlemmer HP, Merkle J, Grobholz R et al (2003) Can pre-operative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens? Eur Radiol 3:3
25.
26.
27.
Li WW (2000) Tumor angiogenesis: molecular pathology, therapeutic targeting, and imaging. Acad Radiol 7:800–811PubMedCrossRef
28.
Riches SF, Payne GS, Morgan VA et al (2009) MRI in the detection of prostate cancer: combined apparent diffusion coefficient, metabolite ratio, and vascular parameters. AJR Am J Roentgenol 193:1583–1591PubMedCrossRef
29.
Huisman HJ, Engelbrecht MR, Barentsz JO (2001) Accurate estimation of pharmacokinetic contrast-enhanced dynamic MRI parameters of the prostate. J Magn Reson Imaging 13:607–614PubMedCrossRef
30.
McMahon CJ, Bloch BN, Lenkinski RE, Rofsky NM (2009) Dynamic contrast-enhanced MR imaging in the evaluation of patients with prostate cancer. Magn Reson Imaging Clin N Am 17:363–383PubMedCrossRef
31.
Ocak I, Bernardo M, Metzger G et al (2007) Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters. AJR Am J Roentgenol 189:849PubMedCrossRef
32.
Engelbrecht MR, Huisman HJ, Laheij RJ et al (2003) Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. Radiology 229:248–254PubMedCrossRef
33.
Huch Boni RA, Boner JA, Lutolf UM, Trinkler F, Pestalozzi DM, Krestin GP (1995) Contrast-enhanced endorectal coil MRI in local staging of prostate carcinoma. J Comput Assist Tomogr 19:232–237PubMedCrossRef
34.
Ito H, Kamoi K, Yokoyama K, Yamada K, Nishimura T (2003) Visualization of prostate cancer using dynamic contrast-enhanced MRI: comparison with transrectal power Doppler ultrasound. Br J Radiol 76:617–624PubMedCrossRef
35.
Ogura K, Maekawa S, Okubo K et al (2001) Dynamic endorectal magnetic resonance imaging for local staging and detection of neurovascular bundle involvement of prostate cancer: correlation with histopathologic results. Urology 57:721–726PubMedCrossRef
36.
Bloch BN, Rofsky NM, Baroni RH, Marquis RP, Pedrosa I, Lenkinski RE (2004) 3 Tesla magnetic resonance imaging of the prostate with combined pelvic phased-array and endorectal coils; Initial experience(1). Acad Radiol 11:863–867PubMed
37.
Futterer JJ, Scheenen TW, Huisman HJ et al (2004) Initial experience of 3 tesla endorectal coil magnetic resonance imaging and 1H-spectroscopic imaging of the prostate. Invest Radiol 39:671–680PubMedCrossRef
38.
Futterer JJ, Heijmink SW, Scheenen TW et al (2006) Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology 241:449–458PubMedCrossRef
39.
Futterer JJ, Heijmink SW, Scheenen TW et al (2006) Prostate cancer: local staging at 3-T endorectal MR imaging–early experience. Radiology 238:184–191PubMedCrossRef
40.
Heijmink SW, Futterer JJ, Hambrock T et al (2007) Prostate cancer: body-array versus endorectal coil MR imaging at 3 T–comparison of image quality, localization, and staging performance. Radiology 244:184–195PubMedCrossRef
41.
Augustin H, Fritz GA, Ehammer T, Auprich M, Pummer K (2009) Accuracy of 3-Tesla magnetic resonance imaging for the staging of prostate cancer in comparison to the Partin tables. Acta Radiol 50:562–569PubMedCrossRef
42.
Miao H, Fukatsu H, Ishigaki T (2007) Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging. Eur J Radiol 61:297–302PubMedCrossRef
43.
Futterer JJ, Engelbrecht MR, Jager GJ et al (2007) Prostate cancer: comparison of local staging accuracy of pelvic phased-array coil alone versus integrated endorectal-pelvic phased-array coils. Local staging accuracy of prostate cancer using endorectal coil MR imaging. Eur Radiol 17:1055–1065PubMedCrossRef
44.
White S, Hricak H, Forstner R et al (1995) Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology 195:385–390PubMed
45.
Fuse H, Okumura A, Satomi S, Kazama T, Katayama T (1992) Evaluation of seminal vesicle characteristics by ultrasonography before and after ejaculation. Urol Int 49:110–113PubMedCrossRef
46.
Rosen Y, Bloch BN, Lenkinski RE, Greenman RL, Marquis RP, Rofsky NM (2007) 3 T MR of the prostate: reducing susceptibility gradients by inflating the endorectal coil with a barium sulfate suspension. Magnet Resonance Med 57:898–904CrossRef
47.
Claus FG, Hricak H, Hattery RR (2004) Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy. Radiographics 24:S167–S180PubMedCrossRef
48.
Degani H, Gusis V, Weinstein D, Fields S, Strano S (1997) Mapping pathophysiological features of breast tumors by MRI at high spatial resolution. Nat Med 3:780–782PubMedCrossRef
49.
(2002) AJCC Cancer Staging Manual, 6th edition edn. Springer-Verlag, New York
50.
Obuchowski NA (2003) Receiver operating characteristic curves and their use in radiology. Radiology 229:3–8PubMedCrossRef
51.
Obuchowski NA, Goske MJ, Applegate KE (2001) Assessing physicians' accuracy in diagnosing paediatric patients with acute abdominal pain: measuring accuracy for multiple diseases. Stat Med 20:3261–3278PubMedCrossRef
52.
Zhou XN, Obuchowski NA, McClish DK (2002) Statistical methods in diagnostic medicine. Wiley, New York
53.
Agresti A, Coull BA (1996) Order-restricted tests for stratified comparisons of binomial proportions. Biometrics 52:1103–1111PubMedCrossRef
54.
Agresti A, Coull BA (1998) Approximate is better than “exact” for interval estimation of binomial proportions. American Statistician 52:119–126
55.
SAS (2000) SAS/STAT user’s guide V. SAS Institute, Cary, NC
56.
Harris RD, Schned AR, Heaney JA (1995) Staging of prostate cancer with endorectal MR imaging: lessons from a learning curve. Radiographics 15:813–829, discussion 829–832PubMed
57.
Futterer JJ, Engelbrecht MR, Huisman HJ et al (2005) Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers. Radiology 237:541–549PubMedCrossRef
58.
Alpert HR, Hillman BJ (2004) Quality and variability in diagnostic radiology. J Am Coll Radiol 1:127–132PubMedCrossRef
59.
60.
Brajtbord JS, Lavery HJ, Nabizada-Pace F, Senaratne P, Samadi DB (2011) Endorectal magnetic resonance imaging has limited clinical ability to preoperatively predict pT3 prostate cancer. BJU Int 107:1419–1424PubMedCrossRef
61.
Epstein JI, Carmichael MJ, Pizov G, Walsh PC (1993) Influence of capsular penetration on progression following radical prostatectomy: a study of 196 cases with long-term followup. J Urol 150:135–141PubMed
62.
Langlotz C, Schnall M, Pollack H (1995) Staging of prostatic cancer: accuracy of MR imaging. Radiology 194:645–646, discussion 647–648PubMed
63.
Manzone TA, Malkowicz SB, Tomaszewski JE, Schnall MD, Langlotz CP (1998) Use sf endorectal MR imaging to predict prostate carcinoma recurrence after radical prostatectomy. Radiology 209:537–542PubMed
64.
Haider MA, van der Kwast TH, Tanguay J et al (2007) Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR Am J Roentgenol 189:323–328PubMedCrossRef
65.
Hoeks CM, Barentsz JO, Hambrock T et al (2011) Prostate cancer: multiparametric MR imaging for detection, localization, and staging. Radiology 261:46–66PubMedCrossRef
66.
AJCC (2010) AJCC cancer staging manual, 7th edn. Springer, New York
Metadata
Title
Prediction of prostate cancer extracapsular extension with high spatial resolution dynamic contrast-enhanced 3-T MRI
Authors
B. Nicolas Bloch
Elizabeth M. Genega
Daniel N. Costa
Ivan Pedrosa
Martin P. Smith
Herbert Y. Kressel
Long Ngo
Martin G. Sanda
William C. DeWolf
Neil M. Rofsky
Publication date
01-10-2012
Publisher
Springer-Verlag
Published in
European Radiology / Issue 10/2012
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-012-2475-5

Other articles of this Issue 10/2012

European Radiology 10/2012 Go to the issue

Erratum

Erratum to: Follow-up of coiled intracranial aneurysms: comparison of 3D time-of-flight and contrast-enhanced magnetic resonance angiography at 3T in a large, prospective series

Hepatobiliary-Pancreas

Optimising diffusion-weighted MR imaging for demonstrating pancreatic cancer: a comparison of respiratory-triggered, free-breathing and breath-hold techniques

Computed Tomography

The effect of iterative reconstruction on computed tomography assessment of emphysema, air trapping and airway dimensions

Computed Tomography

Ventilation imaging of the paranasal sinuses using xenon-enhanced dynamic single-energy CT and dual-energy CT: a feasibility study in a nasal cast

Hepatobiliary-Pancreas

Differentiation of neoplastic from bland macroscopic portal vein thrombi using dual-energy spectral CT imaging: a pilot study

Neuro

Follow-up of coiled intracranial aneurysms: comparison of 3D time-of-flight and contrast-enhanced magnetic resonance angiography at 3T in a large, prospective series